PBM Consulting
TrumpRx: Will it impact Rx benefit plans?
The current administration is looking to make many popular drugs more accessible. Could these efforts impact your pharmacy benefit plan?
Read more
Stay up to date on the issues impacting the industry and be the first to hear about news and changes at Rael & Letson.
The current administration is looking to make many popular drugs more accessible. Could these efforts impact your pharmacy benefit plan?
Read moreDrug rebates are meant to lower costs, but limited transparency and misaligned incentives raise questions. Learn how employers can evaluate PBM practices and ensure their plan delivers real value and long-term savings.
Read moreWe are excited to welcome Martin Fornataro, Pharm.D., to our PBM Consulting team.
Read moreHigh claims costs and the high demand of popular weight loss medications can lead to necessary plan exclusions, but is exclusion the right path?
Read moreNeed to benchmark your current agreement? Help negotiate a favorable deal? Find lower cost options for expensive medications? We can help.
Read moreBiologics represent a hefty portion of pharmaceutical spending in the U.S., yet more affordable biosimilars remain underutilized.
Read more